C4 Therapeutics (CCCC) Stock Price
$2.66 2.6%
to add to portfolio
AI Score
-
Alternative
6 -
Fundamental
2 -
Technical
5
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals. Scores are designed to reflect relative strength or weakness across these factors, helping users compare companies and track changes over time.
Sign up to get access to more historical data and insights on C4 Therapeutics, AI stock picks, stock alerts and much more.
CCCC AI Stock Analysis
AI stock analysis for CCCC is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like C4 Therapeutics (CCCC) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
C4 Therapeutics (CCCC) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of C4 Therapeutics (CCCC), currently trading at $2.66, will... Sign up to access price prediction.
About CCCC
-
C4 Therapeutics, Inc.
-
Symbol
CCCC
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
189.3M
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$19.97 1.4% |
8 |
 |
Inovio Pharmaceuticals INO |
$2.38 10.2% |
2 |
 |
Moderna MRNA |
$23.51 7.4% |
4 |
 |
Anavex Life Sciences AVXL |
$9.37 2.2% |
5 |
 |
BridgeBio Pharma BBIO |
$51.21 2.6% |
6 |
News
CCCC Alternative Data
Web Traffic
C4 Therapeutics receives an estimated 6182 monthly visitors to c4therapeutics.com, which is up by 42.1% over the last month.
-
Web Traffic
6182
-
Change from Previous Month
42.1%
-
3 Month Change
5.5%
-
YoY Change
5.5%
LinkedIn Followers
16,883 are following C4 Therapeutics on LinkedIn, up by 0.9% over the last month.
-
LinkedIn Followers
16883
-
Daily Change
0%
-
1 Month Change
0.9%
-
3 Month Change
2.7%
-
YoY Change
2.7%
Job Postings
C4 Therapeutics currenly has an estimated 0 open job postings.
-
Job Postings
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
LinkedIn Employees
According to LinkedIn, C4 Therapeutics has 121 employees, down by -1.6% over the last month.
-
LinkedIn Employees
121
-
Daily Change
0%
-
1 Month Change
1.6%
-
3 Month Change
3.2%
-
YoY Change
3.2%
Reddit Mentions
C4 Therapeutics has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Twitter Followers
C4 Therapeutics has 1,816 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.9% over the last month.
-
Twitter Followers
1816
-
Daily Change
0.1%
-
1 Month Change
0.9%
-
3 Month Change
2.5%
-
YoY Change
2.5%
Business Outlook
According to employee reviews, the business outlook among employees at C4 Therapeutics is 63 out of 100 (bullish), down by -23.2% over the last month.
-
Business Outlook
63
-
Change from Previous Month
23.2%
-
3 Month Change
23.2%
-
YoY Change
23.2%
News Mentions
C4 Therapeutics was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
CCCC Financials
CCCC Key Metrics
-
Total Revenue
$5.2M
-
Net Income
-$34.6M
-
Earnings per Share
-$0.49
-
Free cash flow
-$17.9M
-
EBITDA
-$34M
-
EBITDA Ratio
-6.56017
-
Total Assets
$349.6M
CCCC 2-year Revenue & Income
CCCC 2-year Free Cash Flow
CCCC Technicals
CCCC SMA
CCCC RSI
FAQ
What's the current price of C4 Therapeutics (CCCC) Stock?
The price of an C4 Therapeutics (CCCC) share is $2.66.
What's the market cap of C4 Therapeutics?
The current market cap of C4 Therapeutics is 189.3M.
What are some stocks similar to C4 Therapeutics (CCCC) that investors often compare it to?
C4 Therapeutics (CCCC) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for C4 Therapeutics' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast C4 Therapeutics' stock price to be around $2.67 in 2026. Starting from the current price of $2.66, this represents a 0.3% change in price, indicating a neutral outlook for the stock.
How to buy C4 Therapeutics (CCCC) Stock?
C4 Therapeutics stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy C4 Therapeutics shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.